Viral-human chimeric transcript predisposes risk to liver cancer development and progression

Cancer Cell

Volumn 25, Issue 3, 2014, Pages 335-349

  Lau, Chi Chiu ^a   Sun, Tingting ^a   Ching, Arthur K K ^a   He, Mian ^a   Li, Jing Woei ^a   Wong, Alissa M ^a   Co, Ngai Na ^a   Chan, Anthony W H ^a   Li, Pik Shan ^a   Lung, Raymond W M ^a   Tong, Joanna H M ^a   Lai, Paul B S ^a   Chan, Henry L Y ^a   To, Ka Fai ^a   Chan, Ting Fung ^a   Wong, Nathalie ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DIETHYLNITROSAMINE; LONG UNTRANSLATED RNA; UNTRANSLATED RNA; FIBRONECTIN; HBX LINE1 FUSION PROTEIN; TUMOR PROMOTER; UNCLASSIFIED DRUG; UVOMORULIN; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL MOTILITY; DNA FLANKING REGION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE FUNCTION; GENE FUSION; HBX LINE 1 GENE; HUMAN; HUMAN CELL; LIVER CANCER; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RNA HYBRIDIZATION; RNA SEQUENCE; TUMOR GENE; VIRUS DNA CELL DNA INTERACTION; WNT SIGNALING PATHWAY; ANIMAL EXPERIMENT; DNA INTEGRATION; EXON; GENETIC SUSCEPTIBILITY; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

HEPATITIS B VIRUS; MUS MUSCULUS;

ANIMALS; BASE SEQUENCE; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DIETHYLNITROSAMINE; DNA-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; RNA, LONG NONCODING; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME; VIRAL FUSION PROTEINS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84896078786     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2014.01.030     Document Type: Article

References (37)

1. Braconi C., Valeri N., Kogure T., Gasparini P., Huang N., Nuovo G.J., Terracciano L., Croce C.M., Patel T. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 2011, 108:786-791.
2. Bréchot C., Gozuacik D., Murakami Y., Paterlini-Bréchot P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin. Cancer Biol. 2000, 10:211-231.
3. Burns K.H., Boeke J.D. Human transposon tectonics. Cell 2012, 149:740-752.
4. Cabili M.N., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011, 25:1915-1927.
5. Chan K.Y., Lai P.B., Squire J.A., Beheshti B., Wong N.L., Sy S.M., Wong N. Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma. Mod. Pathol. 2006, 19:1546-1554.
6. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995, 13:29-60.
7. Cohen S.B., Graham M.E., Lovrecz G.O., Bache N., Robinson P.J., Reddel R.R. Protein composition of catalytically active human telomerase from immortal cells. Science 2007, 315:1850-1853.
8. Devereux T.R., Stern M.C., Flake G.P., Yu M.C., Zhang Z.Q., London S.J., Taylor J.A. CTNNB1 mutations and β-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol. Carcinog. 2001, 31:68-73.
9. Ding D., Lou X., Hua D., Yu W., Li L., Wang J., Gao F., Zhao N., Ren G., Li L., Lin B. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet. 2012, 8:e1003065.
10. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
11. Feitelson M.A., Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett. 2007, 252:157-170.
12. Fujimoto A., Totoki Y., Abe T., Boroevich K.A., Hosoda F., Nguyen H.H., Aoki M., Hosono N., Kubo M., Miya F., et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 2012, 44:760-764.
13. Gozuacik D., Murakami Y., Saigo K., Chami M., Mugnier C., Lagorce D., Okanoue T., Urashima T., Bréchot C., Paterlini-Bréchot P. Identification of human cancer-related genes by naturally occurring hepatitis B virus DNA tagging. Oncogene 2001, 20:6233-6240.
14. AJCC Cancer Staging Manual 2002, Springer-Verlag, New York. Sixth Edition. F.L. Greene, D.L. Page, I.D. Fleming, A. Fritz, C.M. Balch, D.G. Haller, M. Morrow (Eds.).
15. Hastings P.J., Ira G., Lupski J.R. A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet. 2009, 5:e1000327.
16. Hogan B., Costantini F., Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual 1986, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Huang J., Deng Q., Wang Q., Li K.Y., Dai J.H., Li N., Zhu Z.D., Zhou B., Liu X.Y., Liu R.F., et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat. Genet. 2012, 44:1117-1121.
18. Jiang Z., Jhunjhunwala S., Liu J., Haverty P.M., Kennemer M.I., Guan Y., Lee W., Carnevali P., Stinson J., Johnson S., et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res. 2012, 22:593-601.
19. Kremsdorf D., Soussan P., Paterlini-Brechot P., Brechot C. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 2006, 25:3823-3833.
20. Levin H.L., Moran J.V. Dynamic interactions between transposable elements and their hosts. Nat. Rev. Genet. 2011, 12:615-627.
21. Li J.W., Wan R., Yu C.S., Co N.N., Wong N., Chan T.F. ViralFusionSeq: accurately discover viral integration events and reconstruct fusion transcripts at single-base resolution. Bioinformatics 2013, 29:649-651.
22. Matouk I.J., DeGroot N., Mezan S., Ayesh S., Abu-lail R., Hochberg A., Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007, 2:e845.
23. Matsubara K., Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol. Biol. Med. 1990, 7:243-260.
24. Murakami Y., Saigo K., Takashima H., Minami M., Okanoue T., Bréchot C., Paterlini-Bréchot P. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005, 54:1162-1168.
25. Ørom U.A., Derrien T., Beringer M., Gumireddy K., Gardini A., Bussotti G., Lai F., Zytnicki M., Notredame C., Huang Q., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143:46-58.
26. Pang E., Wong N., Lai P.B., To K.F., Lau W.Y., Johnson P.J. Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines. Genes Chromosomes Cancer 2002, 33:150-159.
27. Panzitt K., Tschernatsch M.M., Guelly C., Moustafa T., Stradner M., Strohmaier H.M., Buck C.R., Denk H., Schroeder R., Trauner M., Zatloukal K. Characterization of HULC, a novel gene with strikingup-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132:330-342.
28. Polette M., Mestdagt M., Bindels S., Nawrocki-Raby B., Hunziker W., Foidart J.M., Birembaut P., Gilles C. β-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs 2007, 185:61-65.
29. Sánchez-Tilló E., de Barrios O., Siles L., Cuatrecasas M., Castells A., Postigo A. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc. Natl. Acad. Sci. USA 2011, 108:19204-19209.
30. Shukla R., Upton K.R., Muñoz-Lopez M., Gerhardt D.J., Fisher M.E., Nguyen T., Brennan P.M., Baillie J.K., Collino A., Ghisletti S., et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 2013, 153:101-111.
31. Sung W.K., Zheng H., Li S., Chen R., Liu X., Li Y., Lee N.P., Lee W.H., Ariyaratne P.N., Tennakoon C., et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 2012, 44:765-769.
32. Sze K.M., Chu G.K., Lee J.M., Ng I.O. C-terminal truncated hepatitis B virus X protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 2013, 57:131-139.
33. Toh S.T., Jin Y., Liu L., Wang J., Babrzadeh F., Gharizadeh B., Ronaghi M., Toh H.C., Chow P.K., Chung A.Y., et al. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. Carcinogenesis 2013, 34:787-798.
34. Whittaker S., Marais R., Zhu A.X. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010, 29:4989-5005.
35. Wong C.M., Fan S.T., Ng I.O. β-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 2001, 92:136-145.
36. Xu W., Seok J., Mindrinos M.N., Schweitzer A.C., Jiang H., Wilhelmy J., Clark T.A., Kapur K., Xing Y., Faham M., et al. Human transcriptome array for high-throughput clinical studies. Proc. Natl. Acad. Sci. USA 2011, 108:3707-3712. Inflammation and Host Response to Injury Large-Scale Collaborative Research Program.
37. Yang Z., Zhou L., Wu L.M., Lai M.C., Xie H.Y., Zhang F., Zheng S.S. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 2011, 18:1243-1250.